Second Line Erlotinib (Tarceva) Plus Digoxin in Non-Small Cell Lung Cancer

Clinical trial NCT00281021 · TERMINATED

Trial details

NCT number: NCT00281021
Sponsor: University of Louisville
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Carcinoma, Non-Small Cell Lung

Start date: 2006-02-01
Primary completion: 2010-12-01
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.